For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

Roundtable Session: What is the Future of MSCs? Navigating the Path Forward
Sunday, September 10, 2023 09:15 AM - 10:15 AM  
337 AB
Moderator
Daniel J. Weiss, MD, PhD, University of Vermont, USA

Panelists
Raghavan Chinnadurai, PhD, Mercer School of Medicine, USA
Charles Cox, MD, University of Texas McGovern Medical School, USA
Jacques Galipeau, MD, FRCP(C), University of Wisconsin in Madison, USA
Kilian Kelly, PhD, Cynata Therapeutics , USA


Exploring different approaches to enhance MSC in order to be successful in the clinic

Session Objectives
  1. Review current status of clinical trials utilizing MSCs
  2. Discuss issues and barriers contributing to the lack of success in clinical trials to date
  3. Discuss evolving understanding of MSC mechanisms of actions
  4. Devising strategies for increasing success of clinical investigations

Daniel Weiss
Professor of Medicine
University of Vermont
Moderator


Raghavan Chinnadurai PhD
Assistant Professor
Mercer School of Medicine
Panelist


Charles Cox MD
George and Cynthia Mitchell Distinguished Chair in Neurosciences; Clare A. Glassell Distinguished Chair in Pediatric Surgery; Director of the Pediatric Trauma Program at Children’s Memorial Hermann H
University of Texas McGovern Medical School
Panelist


Jacques Galipeau MD FRCP(C)
Don and Marilyn Anderson Professor in Oncology, Associate Dean for Therapeutics Development
University of Wisconsin in Madison
Panelist


Kilian Kelly PhD
Chief Executive Officer and Managing Director
Cynata Therapeutics
Panelist